Patient Comprehension of Medication Guides for Asthma and Chronic Obstructive Pulmonary Disease Medications
Tóm tắt
Từ khóa
Tài liệu tham khảo
FDA. Medication guides: distribution requirements and inclusion in risk evaluation and mitigation strategies (REMS). http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM244570.pdf. Accessed October 24, 2013.
Wolf MS, Davis TC, Shrank WH, Neuberger M, Parker RM. A critical review of FDA-approved medication guides. Patient Educ Couns. 2006;62:316–322.
Wolf MS, King J, Wilson EA, et al. Usability of FDA-approved medication guides. J Gen Intern Med. 2012;27:1714–1720.
Shiffman S, Gerlach KK, Sembower MA, Rohay JM. Consumer understanding of prescription drug information: an illustration using an antidepressant medication. Ann Pharmacother. 2011;45:452–458.
Dusetzina SB, Higashi AS, Dorsey ER, et al. Impact of FDA drug risk communications on health care utilization and health behaviors: a systematic review. Med Care. 2012;50:466–478.
FDA. Serevent Diskus medication guide. http://www.fda.gov/downloads/Drugs/DrugSafety/ucm089125.pdf. Accessed October 24, 2013.
FDA. Advair Diskus medication guide. http://www.fda.gov/downloads/Drugs/DrugSafety/ucm111326.pdf. Accessed October 24, 2013.
FDA. Drug safety communication: new safety requirements for long-acting inhaled asthma medications called long-acting beta-agonists (LABAs). http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm200776.htm. Accessed October 24, 2013.
ISPE. Guidelines for good pharmacoepidemilogical practices (GPP). Pharmacoepidemiol Drug Saf. 2008;17:200–208.
Davis TC, Long SW, Jackson RH, et al. Rapid estimate of adult literacy in medicine: a shortened screening instrument. Fam Med. 1993;25:391–395.
FDA. Guidance for industry label comprehension studies for nonprescription drug products. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM143834.pdf. Accessed October 24, 2013.
Zeger SL, Liang KY, Self SG. The analysis of binary longitudinal data with time independent covariates. Biometrika. 1985;72:31–38.
Doak CC, Doak LG, Root JH. Teaching Patients With Low Literacy Skills. 2nd ed. Philadelphia, PA: Lippincott; 1996.
Wolf MS, Davis TC, Bass PF, et al. Improving prescription drug warnings to promote patient comprehension [Erratum in: Arch Intern Med. 2010;170:608]. Arch Intern Med. 2010;170:50–56.
Allen LaPointe NM, Pappas P, Deverka P, Anstrom KJ. Patient receipt and understanding of written information provided with isotretinoin and estrogen prescriptions. J Gen Intern Med. 2007;22:98–101.
You WB, Grobman W, Davis T, Curtis LM, Bailey SC, Wolf M. Improving pregnancy drug warnings to promote patient comprehension. Am J Obstet Gynecol. 2011;204:318.e1–318.e5.
Disantostefano RL, Yeakey A, Raphiou I, Stempel D. An evaluation of asthma medication utilization for risk evaluation and mitigation strategies (REMS) in the United States: 2005–2011. J Asthma. 2013;50:776–782.
Davis TC, Federman AD, Bass PF 3rd, et al. Improving patient understanding of prescription drug label instructions. J Gen Intern Med. 2009;24:57–62.
Rosas-Salazar C, Apter AJ, Canino G, Celedón JC. Health literacy and asthma. J Allergy Clin Immunol. 2012;129:935–942.
Apter AJ, Wan F, Reisine S, et al. The association of health literacy with adherence and outcomes in moderate-severe asthma. J Allergy Clin Immunol. 2013;132:321–327.
Federman AD, Wolf MS, Sofianou A, et al. Asthma outcomes are poor among older adults with low health literacy [published online October 8, 2013]. J Asthma.
Roberts NJ, Ghiassi R, Partridge MR. Health literacy in COPD. Int J Chron Obstruct Pulmon Dis. 2008;3:499–507.
Miller MJ, Schmitt MR, Allison JJ, Cobaugh DJ, Ray MN, Saag KG. The role of health literacy and written medicine information in nonsteroidal antiinflammatory drug risk awareness. Ann Pharmacother. 2010;44:274–284.
Enger C, Younus M, Petronis KR, Mo J, Gately R, Seeger JD. The effectiveness of varenicline medication guide for conveying safety information to patients: a REMS assessment survey. Pharmacoepidemiol Drug Saf. 2013;22:705–715.
Dal Pan GJ. Commentary on “The effectiveness of varenicline medication guide for conveying safety information to patients: a REMS assessment survey” by Enger et al. Pharmacoepidemiol Drug Saf. 2013;22:716–718.
Papay JI, Fritz D, Catu T, Ellis M, Debussey S. Assessment of a simplified format of written patient prescription drug information. Drug Inf J. 2010;44:375–391.
Aker J, Beck M, Papay JI, et al. Consumers better understand and prefer simplified written drug information: an evaluation of 2 novel formats versus the current CMI. Ther Innov Regul Sci. 2013;47:125–132.
Katz MG, Kripalani S, Weiss BD. Use of pictorial aids in medication instructions: a review of the literature. Am J Health Syst Pharm. 2006;63:2391–2397.
Schillinger D, Piette J, Grumbach K, et al. Closing the loop: physician communication with diabetic patients who have low health literacy. Arch Intern Med. 2003;163:83–90.
US Department of Education. The health literacy of America’s adults: results from the 2003 national assessment of adult literacy. http://nces.ed.gov/pubs2006/2006483.pdf. Accessed October 24, 2013.
Brookings Institution, Engelberg Center for Health Care Reform. Patient medication information. http://www.brookings.edu/about/centers/health/projects/pmi. Accessed October 24, 2013.
Barlas S. Pharmacy provisions of health care legislation are still viable: industry’s agenda is clear, but its future path is not. P T. 2010;35:142–157.
US Food and Drug Administration. Risk evaluation and mitigation strategy (REMS) assessments: social science methodologies to assess goals related to knowledge. http://www.fda.gov/Drugs/NewsEvents/ucm292337.htm. Accessed October 24, 2013.